Cite
APA Citation
Morra, F., Merolla, F., D'Abbiero, D., Ilardi, G., Campione, S., Monaco, R., Guggino, G., Ambrosio, F., Staibano, S., Cerrato, A., Visconti, R., & Celetti, A. (2019). analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma. Lung cancer, 135, 56–65. http://access.bl.uk/ark:/81055/vdc_100089675451.0x000048